The expression levels of three pivotal receptors in breast cancer—estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu)—help categorize it into four primary molecular subtypes. This evidence concerns the gene ERBB2 and breast cancer.